Evidence map›Paper›PMID 36778406›Full record

ArticlebioRxiv : the preprint server for biology2023

Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants.

Jonah Einson, Dafni Glinos, Eric Boerwinkle, Peter Castaldi, Dawood Darbar, Mariza de Andrade, Patrick Ellinor, Myriam Fornage, Stacey Gabriel, Soren Germer and 24 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 6 countries.

Jonah EinsonDepartment of Biomedical Informatics, Columbia University.
Dafni GlinosNew York Genome Center.
Eric BoerwinkleUniversity of Texas Health at Houston.
Peter CastaldiDepartment of Medicine, Brigham & Women's Hospital.
Dawood DarbarDepartment of Cardiology, University of Illinois at Chicago.
Mariza de AndradeDepartment of Quantitative Health Sciences, Mayo Clinic.
Patrick EllinorCorrigan Minehan Heart Center, Massachusetts General Hospital.
Myriam FornageBrown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health at Houston.
Stacey GabrielBroad Institute.
Soren GermerNew York Genome Center.
Richard GibbsDepartment of Molecular and Human Genetics, Baylor College of Medicine Human Genome Sequencing Center.
Craig P HershChanning Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.
Jill JohnsenDepartment of Hematology, University of Washington.
Robert KaplanDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine.
Barbara A KonkleDepartment of Hematology, University of Washington.
Charles KooperbergFred Hutchinson Cancer Research Center.
Rami NassirDepartment of Pathology, School of Medicine, Umm Al-Qura University.
Ruth J F LoosEnvironmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai.
Deborah A MeyersDepartment of Medicine, University of Arizona.
Braxton D MitchellDepartment of Medicine, University of Maryland School of Medicine.
Bruce PsatyCardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Systems and Population Health, University of Washington.
Ramachandran S VasanDepartment of Medicine, Boston University.
Stephen S RichPublic Health Sciences, University of Virginia.
Michael RienstraClinical Cardiology, UMGC Cardiology.
Jerome I RotterThe Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
Aabida SaferaliChanning Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.
M Benjamin ShoemakerDepartment of Medicine, Vanderbilt University.
Edwin SilvermanChanning Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham & Women's Hospital.
Albert Vernon SmithDepartment of Biostatistics, University of Michigan.
NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
Pejman MohammadiDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute.
Stephane E CastelNew York Genome Center.
Ivan IossifovNew York Genome Center.
Tuuli LappalainenDepartment of Systems Biology, Columbia University.
Brigham and Women's Hospital · USNew York Genome Center · USUniversity of Washington · USAlbert Einstein College of Medicine · USBoston University · USBroad Institute · USBrown Foundation · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACold Spring Harbor Laboratory · USHarbor–UCLA Medical Center · USHuman Genome Sciences (United States) · USKTH Royal Institute of Technology · SEMassachusetts General Hospital · USScripps Research Institute · USThe University of Texas Health Science Center at Houston · USUmm al-Qura University · SAUniversity Medical Center · USUniversity of Arizona · USUniversity of Illinois Chicago · USUniversity of Maryland, Baltimore · US

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
Center for Common Disease GeneticsUM1HG008895 · NHGRI · BROAD INSTITUTE, INC. · PI DALY, MARK JOSEPH, GABRIEL, STACEY · 2016 to 2020
$111.2M
Genomic Architecture of Common Disease in Diverse Populations: WGS of Ongoing Hemorrhagic Stroke Study SupplementUM1HG008898 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2016 to 2020
$77.0M
Supplement Proposal: Accelerated Genome Aggregation and Joint Variant Calling EffortUM1HG008853 · NHGRI · WASHINGTON UNIVERSITY · PI HALL, IRA M, MILBRANDT, JEFFREY D · 2016 to 2020
$76.2M
New York Center for Collaborative Research In Common Disease Genomics: Genome Aggregation and Joint Variant Calling for CCDG Freeze2UM1HG008901 · NHGRI · NEW YORK GENOME CENTER · PI MANIATIS, THOMAS P, WIGLER, MICHAEL H · 2016 to 2020
$56.6M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Studies of Rare Genetic Variation in the Isolated Population of SardiniaR01HL117626 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABECASIS, GONCALO · 2013 to 2016
$10.5M
Rare variants and NHLBI traits in deeply phenotyped cohortsR01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2014 to 2016
$8.9M
Rare variants and NHLBI traits in deeply phenotyped cohortsU01HL120393 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, RICE, KENNETH M. · 2017 to 2018
$5.6M
Statistical models for fine-mapping and interpretation of schizophrenia-associated lociR01MH106842 · NIMH · NEW YORK GENOME CENTER · PI BUSSEMAKER, HARMEN J, LAPPALAINEN, TUULI · 2015 to 2024
$5.0M
NHGRI NIH HHS U54 HG003067NHGRI NIH HHS U54 HG003273NHGRI NIH HHS UM1 HG008853NHGRI NIH HHS UM1 HG008895NHGRI NIH HHS UM1 HG008898NHGRI NIH HHS UM1 HG008901NHLBI NIH HHS HHSN268201500014CNHLBI NIH HHS HHSN268201500015CNHLBI NIH HHS HHSN268201500016CNHLBI NIH HHS HHSN268201800001CNHLBI NIH HHS K01 HL157613NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL117626NHLBI NIH HHS R01 HL120393NHLBI NIH HHS R01 HL121007NHLBI NIH HHS U01 HL120393NIEHS NIH HHS HHSN268201600033CNIGMS NIH HHS R01 GM122924NIGMS NIH HHS R01 GM140287NIMH NIH HHS R01 MH106842
6 · The paper itself

Abstract

Exonic variants present some of the strongest links between genotype and phenotype. However, these variants can have significant inter-individual pathogenicity differences, known as variable penetrance. In this study, we propose a model where genetically controlled mRNA splicing modulates the pathogenicity of exonic variants. By first cataloging exonic inclusion from RNA-seq data in GTEx v8, we find that pathogenic alleles are depleted on highly included exons. Using a large-scale phased WGS data from the TOPMed consortium, we observe that this effect may be driven by common splice-regulatory genetic variants, and that natural selection acts on haplotype configurations that reduce the transcript inclusion of putatively pathogenic variants, especially when limiting to haploinsufficient genes. Finally, we test if this effect may be relevant for autism risk using families from the Simons Simplex Collection, but find that splicing of pathogenic alleles has a penetrance reducing effect here as well. Overall, our results indicate that common splice-regulatory variants may play a role in reducing the damaging effects of rare exonic variants.

Identifiers

PMID36778406
PMCPMC9915611
OpenAlexW4318677401

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.